Barely Significant
← all excerpts

Is glucose control important for prevention of cardiovascular disease in diabetes?

Diabetes Care · 2013 · PMC3920786 · PMID 23882055

Europe PMCDOI
2
hedged sentences
—
closest p
—
boldest claim

The sentences

did not reach statistical significanceno p-value reported
On the other hand, no significant improvement in cardiovascular risk was observed with intensification of diabetes therapy in the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (ADVANCE) ( 9 ) and the Veterans Affairs Diabetes Trial (VADT) ( 10 ); in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial ( 11 ), the reduction in cardiovascular morbidity in the intensified therapy group did not reach statistical significance, due to the premature interruption because of increased mortality.

also in 111,027 other papers

showed a trendno p-value reported
The Diabetes Control and Complications Trial (DCCT) showed a trend toward a 41% risk reduction of cardiovascular events in type 1 diabetes ( 6 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.